Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study

BACKGROUND: There were some reports of peripheral artery occlusive disease (PAOD) associated with nilotinib usage in chronic myeloid leukemia (CML). These complications in other tyrosine kinase inhibitors are revealed as unknown. MATERIALS AND METHODS: We determined the prevalence of PAOD in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanathammethee, Thanawat, Tantiworawit, Adisak, Rattarittamrong, Ekarat, Chai-Adisaksopha, Chatree, Hantrakool, Sasinee, Phrommintikul, Arintaya, Wongcharoen, Wanwarang, Gunaparn, Siriluck, Norasetthada, Lalita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734569/
https://www.ncbi.nlm.nih.gov/pubmed/29276418
http://dx.doi.org/10.1177/1179546817747258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734569/
https://www.ncbi.nlm.nih.gov/pubmed/29276418
http://dx.doi.org/10.1177/1179546817747258

Ejemplares similares